Having said that, details concerning ADRs were not offered, which limits the full knowledge of the noticed higher variability in tramadol and ODT exposure and the risk of ADRs. A better quantity of members could improve a chance to characterise interactions in between participant attributes and tramadol as well as pharmacokinetic parameters of tram